EUVIMEDOpdag EUVIMED
BeobachtungsstudieOpen access

Factors Associated with Adequate Quality of Life Levels in HIV Patients During a Five-Year Longitudinal Study

Enrique Contreras-Macías iD, Ramón Morillo-Verdugo iD

Revista Española de Quimioterapia · 2025

DOI: 10.37201/req/032.2025 ↗

At a glance

Beobachtungsstudie in Revista Española de Quimioterapia, 2025. Written by Enrique Contreras-Macías and 1 co-authors. Institution: Hospital San Juan De Dios, Sevilla, España. enriquecm92@gmail.com. Major MEDLINE topics: Quality of Life, HIV Infections. Cited 2 times so far (Crossref). The full text is freely available in PubMed Central.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Introduction

Advances in antiretroviral therapy (ARV) have improved the life expectancy of people living with HIV (PLWH), shifting the focus to quality of life (QoL). However, aging, polypharmacy, and comorbidities pose challenges. This study aimed to evaluate the evolution of QoL over five years and identify associated sociodemographic, clinical, and pharmacotherapeutic factors.

Methods

A single-center retrospective observational study was conducted in PLWH attending a tertiary hospital outpatient pharmacy. QoL was assessed using the EQ-5D-5L questionnaire. Sociodemographic, clinical, and pharmacotherapeutic variables—including age, polypharmacy, comorbidities, and Medication Regimen Complexity Index (MRCI)—were analyzed. Multivariate logistic regression identified predictors of good QoL, defined as a Visual Analogue Scale (VAS) score ≥76.

Results

A total of 437 PLWH were included with median age 52 years. The participants were majority male (82.8%). Throughout the study, mean VAS scores remained stable, with 63.7–73.4% of participants reporting good QoL each year. The most frequently reported issues were related to mobility (8.9%), pain/discomfort (5.1%), and anxiety/depression (3.0%). Multivariate analysis showed that advanced age (OR: 1.55, 95%CI: 1.14–2.11), polypharmacy (OR: 1.87, 95%CI: 1.35–2.59), comorbidities (OR: 2.13, 95%CI: 1.76–2.89), and socioeconomic problems (OR: 2.47, 95%CI: 1.44–4.21) were significantly associated with lower QoL.

Conclusion

Aging, polypharmacy, and socioeconomic disparities significantly impact QoL in PLWH. Integrating QoL assessments into routine care and addressing these factors through comprehensive management strategies could enhance long-term well-being.

Subjects

MeSH terms (MEDLINE)

Quality of LifeHIV InfectionsHumansMaleFemaleMiddle AgedRetrospective StudiesAdultLongitudinal StudiesPolypharmacyAgedSurveys and QuestionnairesAnti-HIV AgentsComorbidity

Author keywords

HIVHealth outcomesHealth-related quality of lifeHighly active antiretroviral therapy (HAART)Pharmaceutical care

Substances

Anti-HIV Agents

Authors and institutions

  • Hospital San Juan De Dios, Sevilla, España. enriquecm92@gmail.com.
  • Hospital Universitario Virgen de Valme, Sevilla, España.

ORCID profiles: Enrique Contreras-Macías, Ramón Morillo-Verdugo

Cite

APA

Contreras-Macías, E., & Morillo-Verdugo, R. (2025). Factors Associated with Adequate Quality of Life Levels in HIV Patients During a Five-Year Longitudinal Study. Revista Española de Quimioterapia. https://doi.org/10.37201/req/032.2025

Vancouver

Contreras-Macías E, Morillo-Verdugo R. Factors Associated with Adequate Quality of Life Levels in HIV Patients During a Five-Year Longitudinal Study. Revista Española de Quimioterapia. 2025. doi:10.37201/req/032.2025

BibTeX
@article{ContrerasMacas2025,
  author = {Contreras-Macías, Enrique and Morillo-Verdugo, Ramón},
  title = {Factors Associated with Adequate Quality of Life Levels in HIV Patients During a Five-Year Longitudinal Study},
  journal = {Revista Española de Quimioterapia},
  year = {2025},
  doi = {10.37201/req/032.2025}
}
Start for free →